1. Home
  2. BMI vs TMDX Comparison

BMI vs TMDX Comparison

Compare BMI & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BMI

Badger Meter Inc.

HOLD

Current Price

$147.46

Market Cap

4.3B

Sector

Industrials

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$123.82

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMI
TMDX
Founded
1905
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.6B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
BMI
TMDX
Price
$147.46
$123.82
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
$193.14
$154.00
AVG Volume (30 Days)
286.5K
773.0K
Earning Date
04-29-2026
06-01-2026
Dividend Yield
1.06%
N/A
EPS Growth
13.24
382.18
EPS
4.79
4.87
Revenue
N/A
$605,494,000.00
Revenue This Year
$6.52
$24.12
Revenue Next Year
$6.82
$18.69
P/E Ratio
$31.60
$26.03
Revenue Growth
N/A
37.13
52 Week Low
$139.14
$62.42
52 Week High
$256.08
$156.00

Technical Indicators

Market Signals
Indicator
BMI
TMDX
Relative Strength Index (RSI) 42.92 40.73
Support Level $139.14 $123.37
Resistance Level $184.62 $131.86
Average True Range (ATR) 5.48 7.79
MACD 0.19 -1.86
Stochastic Oscillator 27.55 12.11

Price Performance

Historical Comparison
BMI
TMDX

About BMI Badger Meter Inc.

Badger Meter is a provider of water management solutions. The company's solutions encompass measurement and control hardware, connectivity and communication, data visualization and software. Badger Meter has globalised operations, with the vast majority of revenue derived from the USA. The company is an innovator in flow measurement, water quality and control products, serving water utilities, municipalities and commercial and industrial customers world-wide.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: